Weiss Patrick 4
4 · Twist Bioscience Corp · Filed Dec 16, 2021
Insider Transaction Report
Form 4
Weiss Patrick
VP of Operations
Transactions
- Exercise/Conversion
Common Stock
2021-12-14$25.02/sh+827$20,692→ 50,289 total - Sale
Common Stock
2021-12-14$84.00/sh−2,801$235,284→ 47,488 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-14−827→ 19,859 totalExercise: $25.02Exp: 2029-12-09→ Common Stock (827 underlying) - Exercise/Conversion
Common Stock
2021-12-14$26.66/sh+1,974$52,627→ 49,462 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-14−1,974→ 47,376 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,974 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 11, 2021.
- [F2]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.